Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Cancer and Metastasis Reviews

Issue 3-4/2004

Basic radiation research into the new millennium

Content (17 Articles)

Preface

Michael C. Joiner

Michael C. Joiner

Introduction: Basic radiation research into the new millennium

Michael C. Joiner

Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity?

B. Marples

Radiation and the cell cycle, revisited

George D. Wilson

The influence of Ras pathway signaling on tumor radiosensitivity

In Ah Kim, Annemarie T. Fernandes, Anjali K. Gupta, W. Gillies McKenna, Eric J. Bernhard

The p53 protein family and radiation sensitivity: Yes or no?

Andrew R. Cuddihy, Robert G. Bristow

Gene expression profiling after irradiation: Clues to understanding acute and persistent responses?

Andrew R. Snyder, William F. Morgan

Radiation and hypoxia inducible gene therapy systems

Simon D. Scott, Olga Greco

Enhanced radiation response through directed molecular targeting approaches

Spencer J. Collis, Theodore L. DeWeese

Hypoxic gene expression and metastasis

Quynh-Thu Le, Nicholas C. Denko, Amato J. Giaccia

Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifying concept in stress response biology

Douglas R. Spitz, Edouard I. Azzam, Jian Jian Li, David Gius

Microbeam developments and applications: A low linear energy transfer perspective

Marianne Sowa Resat, William F. Morgan

Radiation-induced neoplastic transformation in vitro: Evidence for a protective effect at low doses of low LET radiation

J.L. Redpath

Radiation cytogenetics: From chromosomes to single nucleotides and from metaphase cells to tissues

James D. Tucker

Opioid peptides in cancer

Jakub Fichna, Anna Janecka

Implications of apoptosis regulators in tumorigenesis

Lucia Malaguarnera

Aggressive basal cell carcinoma: Presentation, pathogenesis, and management

Hobart W. Walling, Scott W. Fosko, Pedram A. Geraminejad, Duane C. Whitaker, Christopher J. Arpey

Jan 04
Issue: 1-2/2004
Colorectal Cancer
Jan 05
Issue: 1/2005

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits